Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-08-04
2010-11-02
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S346100
Reexamination Certificate
active
07825149
ABSTRACT:
This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.
REFERENCES:
patent: 4678775 (1987-07-01), Nathanson
patent: 5017596 (1991-05-01), Colombo et al.
patent: 5646153 (1997-07-01), Spada et al.
patent: 6103733 (2000-08-01), Bachmann et al.
patent: 2005/0222135 (2005-10-01), Buschmann et al.
patent: 2006/0178404 (2006-08-01), Bowles
patent: 2007/0155717 (2007-07-01), Allegretti et al.
patent: 2007/0167506 (2007-07-01), Chubb et al.
patent: 2007/0197621 (2007-08-01), Galley et al.
patent: 103 04 374 (2004-08-01), None
patent: 2 681 322 (1993-03-01), None
patent: 7-243054 (1995-09-01), None
patent: 99/28300 (1999-06-01), None
patent: 01/00586 (2001-01-01), None
patent: 01/94318 (2001-12-01), None
patent: 03/092374 (2003-11-01), None
patent: 2004/103959 (2004-12-01), None
patent: 2005/007188 (2005-01-01), None
PCT International Search Report, PCT/IB2007/000071.
Torregrosa et al., “Isoprene-catalyzed lithiation of imidazole: synthesis of 2-(hydroxyalkyl)- and 2-(aminoalkyl) imidazoles”, Tetrahedron, 61:11148-11155, 2005.
Nardi et al., “Research Research on durene derivatives. Note I—hypertensive activity of 2-(2,3,5,6-tetramethylbenzyl)imidazoline and related compounds”, Farmaco, Ed. Sci., 34(9):789-801, 1979.
Stella, “Prodrugs as therapeutics”, Expert Opinion of Therapeutic Patents, 14(3):277-280, 2004.
Wolff et al., Burger's Medicinal Chemistry, 5th Ed., vol. 1, pp. 975-977, 1994.
Testa, “Prodrug research: futile or fertile?”, Biochemical Pharmacology, 68:2097-2106, 2004.
Ettmayer, “Lessons Learned from Marketed and Investigational Prodrugs”, Medicinal Chemistry, 47 (10):2393-2404, 2004.
Huh et al., “A novel synthetic method for 2-arylmethyl substituted imidazolines and imidazoles from 2-aryl-1,1-dibromoethenes”, Tetrahedron, 60:9857-9862, 2004.
Patani and Lavoie, “Bioisosterism: A Rational Approach in Drug Design”, Chem. Rev., 96:3147-3176, 1996.
Miller et al., “Synthesis and alpha2-Adrenoceptor Effects of Substituted Catecholimidazoline and and Catecholimidazole Analogues in Human Platelets”, J. Med. Chem., 33:1138-1144, 1990.
Chubb Nathan Anthony Logan
Cox Mark Roger
Dauvergne Jerome Sebastien
Ewin Richard Andrew
Lauret Christelle
Misiak Paul M.
Pfizer Limited
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
Substituted imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4243375